Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ALCOR Scientific Inc.

ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App




Availability Expanded for CE-Marked Erythrocyte Sedimentation Rate Analyzer

By LabMedica International staff writers
Posted on 13 Aug 2014
An advanced technology erythrocyte sedimentation rate (ESR) analyzer, that delivers results in seconds using small sample, is now available globally.

ALCOR Scientific, Inc. More...
(Smithfield, RI, USA), provider of in vitro diagnostic analyzers and devices for enteral nutrition delivery, has expanded availability of its iSED system for ESR testing to meet growing demand for this advanced technology. Designed, manufactured, and initially launched late 2012 in the USA, the iSED is CE-marked and now available globally, through distributors in Europe, Asia, Africa, South America and North America.

iSED provides accurate, efficient, automated ESR testing – one of the most widely used lab tests worldwide, yet historically one of the most time-consuming and cumbersome to perform. It transforms ESR testing by employing patented technology that delivers accurate results in 20 seconds using a blood sample of just 100 µL, especially important in working with pediatric and geriatric patients. The iSED has a throughput of up to 180 samples per hour, made possible by its random access, continuous feed operation. The system tests samples directly from standard EDTA tubes, reducing both testing costs and contaminated waste. With its closed tube sampling and no disposables required, the iSED greatly speeds processes and improves efficiency, as well as safety for lab clinicians.

The iSED’s high degree of accuracy is enabled by the use of quantitative photometry to measure, in a controlled environment, the formation of the red cell aggregates (Rouleaux) in the most critical phase of the red cell sedimentation. This technology ensures that results obtained, unaffected by variables such as mixing and temperature, accurately reflect the patient’s inflammation status.

“The iSED’s rapid adoption is a testament to its ability to facilitate patient testing through a cost-effective and user-friendly solution that streamlines lab processes,” said Carlo Ruggeri, ALCOR CEO and founder, “Alcor looks forward to introducing new, innovative diagnostic and medical device products driven by the same principles.”

The iSED was recently featured at the American Association of Clinical Chemistry (AACC) Annual Meeting and Expo in Chicago (IL, USA), July 29–31, 2014.

Related Links:

ALCOR Scientific



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.